Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

February 1, 2012

Study Completion Date

February 21, 2012

Conditions

Healthy

Interventions

DRUG

BI 409306

Film-coated tablet

DRUG

Placebo

Film-coated tablet

Trial Locations (1)

1289.3.1 Boehringer Ingelheim Investigational Site, Antwerp